Cargando…

Ethical Aspects of Human Induced Pluripotent Stem Cells and Alzheimer’s Disease: Potentials and Challenges of a Seemingly Harmless Method

Dementia currently affects more than 55 million people worldwide, and scientists predict that this number will continue to rise. The most common form is Alzheimer’s disease (AD), which is triggered, among other things, by dysfunctional cells in the human brain. Stem cell research attempts to counter...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kropf, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578332/ https://www.ncbi.nlm.nih.gov/pubmed/37849627 http://dx.doi.org/10.3233/ADR-230018

Ejemplares similares

When a Seemingly Harmless Prescription Turns into Toxicity
por: Azmaiparashvili, Zurab, et al.
Publicado: (2018)

Seemingly Harmless Differentiated Thyroid Carcinoma Presenting as Bone Metastasis
por: Magalhães, D., et al.
Publicado: (2018)

Alzheimer’s Amyloidopathy: An Alternative Aspect
por: Regland, Björn, et al.
Publicado: (2019)

Locally induced neural stem cells/pluripotent stem cells for in vivo cell replacement therapy
por: Yuan, Ti-Fei, et al.
Publicado: (2008)

Primate embryogenesis predicts the hallmarks of human naïve pluripotency
por: Boroviak, Thorsten, et al.
Publicado: (2017)

Application of ultrasound in the management of TRASH (the radiographic appearance seemed harmless) fractures in preschool children: A review
por: Jia, Guoqiang, et al.
Publicado: (2023)

Formative pluripotency: the executive phase in a developmental continuum
por: Smith, Austin
Publicado: (2017)

Wearable Technologies and Stress: Toward an Ethically Grounded Approach
por: Canali, Stefano, et al.
Publicado: (2023)

Chaotic expression dynamics implies pluripotency: when theory and experiment meet
por: Furusawa, Chikara, et al.
Publicado: (2009)

The harmless people.
por: Thomas, Elizabeth Marshall, 1931-
Publicado: (1959)

Harmless Parasites
Publicado: (1901)

Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring
por: Virgolino, Ana, et al.
Publicado: (2021)

Unraveling Alzheimer’s: Making Sense of the Relationship between Diabetes and Alzheimer’s Disease(1)
por: Schilling, Melissa A.
Publicado: (2016)

Ocular Surface Allostasis—When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience
por: van Setten, Gysbert-Botho
Publicado: (2023)

Anticoagulants for Treatment of Alzheimer’s Disease
por: Grossmann, Klaus
Publicado: (2020)

The mechanistic and evolutionary aspects of the 2′- and 3′-OH paradigm in biosynthetic machinery
por: Safro, Mark, et al.
Publicado: (2013)

The Adult Neurogenesis Theory of Alzheimer’s Disease
por: Abbate, Carlo
Publicado: (2023)

The Harmlessness of Cervical Lacerations
Publicado: (1888)

The DNA Replication Stress Hypothesis of Alzheimer's Disease
por: Yurov, Yuri B., et al.
Publicado: (2012)

The GABA–Working Memory Relationship in Alzheimer’s Disease
por: Mandal, Pravat K., et al.
Publicado: (2017)

Subunits of human condensins are potential therapeutic targets for cancers
por: Wang, Hong-Zhen, et al.
Publicado: (2018)

Do Microglia Default on Network Maintenance in Alzheimer’s Disease?
por: Southam, Katherine A., et al.
Publicado: (2016)

A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors
por: Li, Shengwen Calvin, et al.
Publicado: (2008)

Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics
por: Chiappelli, Francesco, et al.
Publicado: (2007)

The Blood-Brain Barrier and Microvascular Water Exchange in Alzheimer's Disease
por: Anderson, Valerie C., et al.
Publicado: (2011)

Protein interaction network for Alzheimer's disease using computational approach
por: Rao, V Srinivasa, et al.
Publicado: (2013)

Detection of severity in Alzheimer's disease (AD) using computational modeling
por: Kim, Hyunjo
Publicado: (2018)

Transgenerational Interaction of Alzheimer’s Disease with Schizophrenia through Amyloid Evolvability
por: Takamatsu, Yoshiki, et al.
Publicado: (2019)

Neurogenesis Makes a Crucial Contribution to the Neuropathology of Alzheimer’s Disease
por: Young, John K.
Publicado: (2020)

A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
por: Rudge, Jonathan D’Arcy
Publicado: (2022)

Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer’s Disease
por: Fitzgerald, Paul J.
Publicado: (2021)

Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease?
por: Bohr, Iwo J
Publicado: (2005)

Alzheimer's disease gene signature says: beware of brain viral infections
por: Porcellini, Elisa, et al.
Publicado: (2010)

A Hypothesis and Evidence That Mercury May be an Etiological Factor in Alzheimer’s Disease
por: Siblerud, Robert, et al.
Publicado: (2019)

Can Porphyromonas gingivalis Contribute to Alzheimer’s Disease Already at the Stage of Gingivitis?
por: Olsen, Ingar
Publicado: (2021)

Post-Translationally Regulated Protein Arginine-to-Proline Conversion in Alzheimer’s Brains
por: Suzuki, Yuichiro Justin
Publicado: (2022)

The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer’s Disease
por: Rudge, Jonathan D’Arcy
Publicado: (2023)

Alzheimer's disease and HIV associated dementia related genes: I. location and function
por: Shapshak, Paul, et al.
Publicado: (2008)

Alzheimer’s and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid
por: Anderson, G, et al.
Publicado: (2010)

Melatonin and Abeta, Macular Degeneration and Alzheimers Disease: Same Disease, Different Outcomes?
por: Vladan, Bajic, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_86s58112mv72d8d1e46q0odj43